The report highlights the company's progress in corporate social responsibility (CSR) during 2018. The company focuses on four main areas: health and well-being, ethics and transparency, environmental protection, and sustainability foundations. The report highlights the company's efforts to improve access to healthcare through innovation and affordable drug pricing, uphold business ethics and transparency, reduce environmental impact, and foster a sustainable and inclusive business environment.
Issuing Company Baiyunshan Pharmaceutical Holdings Co., Ltd.
Report Type Sustainability Report
Report Language EN
Report Filesize 2.71 MB
No. of Pages 29 pages
Reporting periodJanuary 1, 2018-December 31, 2018
Report Edition11
Assurance Provider Unknown
Reporting Standards GRI; CASS-CSR4.0
Materiality Assessmenttrue